Ocata Therapeutics Inc fka OCAT

[rumper]

FDA Grants Fast Track for Treatment_of Wet AMD

ACTC could very well get Fast Track Designation also,
this may be the reason for such recent tight lip behavior
of the company. ACTC rebuilds the macula. This is
nanotechnology. This is new. This is good.

Fast track is granted for UN-MET medical needs, and also
other reasons. 20-400 to 20-40, and the safety track record
so far, is reason enough to let ACTC pass through the gate
for all the people
suffering from this unmet medical scourge.

from 5/14/2012
FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Treatment of Wet AMD

http://eyewiretoday.com/view.asp?20120514-fda_grants_fast_track_designation_to_ohr_pharmaceuticals_squalamine_eye_drops_for_the_treatment_of_wet_amd